ScinoPharm Taiwan, Ltd. (TPE:1789)

ScinoPharm Taiwan Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14,154	17,436	20,876	20,124	19,492	22,813
Market Cap Growth	-41.38%	-16.48%	3.73%	3.25%	-14.56%	8.46%
Enterprise Value	11,792	14,136	17,530	16,527	16,275	19,607
Last Close Price	17.90	21.61	25.60	24.38	23.17	26.56
PE Ratio	69.16	51.38	72.72	56.98	80.06	80.88
Forward PE	49.72	108.27	102.52	52.60	115.41	115.41
PS Ratio	4.43	5.12	6.55	6.17	7.06	7.40
PB Ratio	1.38	1.66	2.01	1.93	1.85	2.17
P/TBV Ratio	1.38	1.66	2.02	1.93	1.86	2.17
P/FCF Ratio	57.77	37.04	-	37.93	99.76	29.77
P/OCF Ratio	25.44	23.22	90.32	26.01	38.23	24.11
EV/Sales Ratio	3.69	4.15	5.50	5.06	5.89	6.36
EV/EBITDA Ratio	16.37	17.85	23.07	19.93	24.83	25.99
EV/EBIT Ratio	53.95	44.03	55.74	40.76	56.39	52.18
EV/FCF Ratio	48.13	30.03	-	31.15	83.29	25.59
Debt / Equity Ratio	0.07	0.06	0.06	0.07	0.05	0.06
Debt / EBITDA Ratio	1.00	0.83	0.80	0.80	0.83	0.75
Debt / FCF Ratio	2.95	1.44	-	1.28	2.85	0.75
Asset Turnover	0.27	0.29	0.27	0.28	0.24	0.26
Inventory Turnover	1.07	1.32	1.46	1.59	1.14	1.49
Quick Ratio	3.40	6.24	6.52	6.16	8.04	6.59
Current Ratio	5.34	8.61	8.75	7.87	10.73	8.62
Return on Equity (ROE)	1.98%	3.25%	2.76%	3.37%	2.31%	2.71%
Return on Assets (ROA)	1.14%	1.70%	1.66%	2.15%	1.53%	2.00%
Return on Capital (ROIC)	1.24%	1.81%	1.78%	2.28%	1.63%	2.11%
Return on Capital Employed (ROCE)	2.00%	2.90%	2.90%	3.70%	2.60%	3.40%
Earnings Yield	1.45%	1.95%	1.38%	1.75%	1.25%	1.24%
FCF Yield	1.73%	2.70%	-0.18%	2.64%	1.00%	3.36%
Dividend Yield	1.92%	1.62%	1.17%	1.48%	2.07%	1.88%
Payout Ratio	115.91%	69.91%	99.17%	107.46%	162.39%	75.69%
Buyback Yield / Dilution	-0.03%	-0.07%	0.04%	-0.05%	-0.01%	-0.01%
Total Shareholder Return	1.90%	1.55%	1.22%	1.43%	2.06%	1.87%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.